Selected Disorders of the Female Reproductive System

  • Gary R. Newkirk
  • Patricia Ann McGuire


Pelvic pain is one of the most vexing problems encountered by the family physician. The monetary and psychosocial costs are unknown but are assumed to be high. In the United States about 40% of all laparoscopics are done for the evaluation and treatment of pelvic pain.1


Pelvic Pain Assisted Reproductive Technology Pelvic Inflammatory Disease Chronic Pelvic Pain Toxic Shock Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Peterson HB, Hulka JF, Phillips JM. American Association of Gynecologic Laparoscopists’ 1988 membership survey on operative laparoscopy. J Reprod Med 1990;35:587–9.PubMedGoogle Scholar
  2. 2.
    Nolan TE, Elkins TE. Chronic pelvic pain differentiating anatomic from functional causes. Postgrad Med 1993;94:125–8.PubMedGoogle Scholar
  3. 3.
    Toomey TC, Hernandez JT, Gittlelman DF, Hulka JF. Relationship of sexual and physical abuse to pain and psychological assessment variables in chronic pelvic pain. Pain 1993;94:125–8.Google Scholar
  4. 4.
    Ling FW, Slocumb JC. Use of trigger point injections in chronic pelvic pain. Obstet Gynecol Clin North Am 1993; 20:809–15.PubMedGoogle Scholar
  5. 5.
    King Baker P. Musculoskeletal origins of chronic pelvic pain. Obstet Gynecol Clin North Am 1993;20:719–40.Google Scholar
  6. 6.
    King PM, Myers LA, Ling FW, et al. Musculoskeletal factors in chronic pelvic pain. J Psych Obstet Gynaecol 1991;12:87–98.Google Scholar
  7. 7.
    Basu HK. Major common problems: pelvic pain. Br J Hosp Med 1981;26:150.PubMedGoogle Scholar
  8. 8.
    Vercellini P, Fedele L, Arcaini L, et al. Laparoscopy in the diagnoses of chronic pelvic pain in adolescent women. J Reprod Med 1989;34:827.PubMedGoogle Scholar
  9. 9.
    Baker PN, Symonds EM. The resolution of chronic pelvic pain. Am J Obstet Gynecol 1992;166:835.PubMedCrossRefGoogle Scholar
  10. 10.
    McQuay HJ, Carroll D, Glynn CJ: Low dose amitriptyline in the treatment of chronic pain. Anesthesia 1992;47:646–52.CrossRefGoogle Scholar
  11. 11.
    Parsons L, Stovall T. Surgical management of chronic pelvic pain. Obstet Gynecol Clin North Am 1993;20:765–78.PubMedGoogle Scholar
  12. 12.
    Stovall TG, Ling FW, Crawford DA. Hysterectomy for chronic pelvic pain of presumed uterine etiology. Obstet Gynecol 1990;75:676.PubMedGoogle Scholar
  13. 13.
    Sampson JA. Perforating hemorrhagic (chocolate) cysts of the ovary, their importance and especially their relation to pelvic adenomas of the endometrial type. Arch Surg 1921;3: 245–323.CrossRefGoogle Scholar
  14. 14.
    Saltiel E, Garabedian-Ruffalo SM. Pharmacologic management of endometriosis. Clin Pharm 1991;10:518–30.PubMedGoogle Scholar
  15. 15.
    Rawsn JM. Prevalence of endometriosis in asymptomatic women. J Reprod Med 1991;36:513–5.Google Scholar
  16. 16.
    Dawood MY. Endometriosis. In: Gold JJ, Josimovich JB, editors. Gynecologic endocrinology. New York: Plenum, 1987: 387–404.CrossRefGoogle Scholar
  17. 17.
    Moghissi KS. Office management of endometriosis. In: Stenchever MA, editor. Office gynecology. St. Louis: Mosby-Year Book, 1992:413–29.Google Scholar
  18. 18.
    National Center for Health Statistics, McCarthey E. Inpatient utilization of short-stay hospitals by diagnosis: United States, 1980. Hyattsville, MD: National Center for Health Statistics, 1982. DHSS Publ. no. (PHS) 83–1735. (Vital and health statistics; series 13: Data from the National Health Survey, no. 74.)Google Scholar
  19. 19.
    Hurst BS, Rock JA. Endometriosis: pathophysiology, diagnosis, and treatment. Obstet Gynecol Surv 1989;44:297–304.PubMedCrossRefGoogle Scholar
  20. 20.
    Endometriosis and infertility. In: Speroff L, Glass RH, Käse NG, editors. Clinical gynecology, endocrinology, and infertility. 4th ed. Baltimore: Williams & Wilkins, 1989;547–63.Google Scholar
  21. 21.
    Dmowski WP Endometriosis. In: Glass RH, editor. Office gynecology. Baltimore: Williams & Wilkins; 1987:317–36.Google Scholar
  22. 22.
    American College of Obstetricians and Gynecologists. Management of endometriosis. Washington, DC: ACOG, 1985. Technical Bulletin No. 85. Google Scholar
  23. 23.
    Pittaway DE. CA-125 in women with endometriosis. Obstet Gynecol Clin North Am 1989;16:237–52.PubMedGoogle Scholar
  24. 24.
    Koninck PR, Riittinen L, Sepalla M, Cornillie FJ. CA-125 and placental protein 14 concentrations in plasma and perioneal fluid of women with deeply infiltrating pelvic endometriosis. Fértil Steril 1992;57:523–30.Google Scholar
  25. 25.
    Badawy SZA, Cuenea V, Freliech H, Stefanu C. Endometrial antibodies in serum and peritoneal fluid of infertile patients with and without endometriosis. Fértil Steril 1990;53:930–2.Google Scholar
  26. 26.
    Seibel MM. Does minimal endometriosis always require treatment? Contemp Obstet Gynecol 1989;34:27–39.Google Scholar
  27. 27.
    DiZerega GS, Barber DL, Hodgen GD. Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression. Fértil Steril 1980;33:649–53.PubMedGoogle Scholar
  28. 28.
    Barbieri RL. Endometriosis 1990: current treatment approaches. Drugs 1990;39:502–10.PubMedCrossRefGoogle Scholar
  29. 29.
    Fedele L, Bianchi S, Marchin M, Villa L, Brioschi D, Parazzini F. Superovulation with human menopausal gonadotropins in the treatment of infertility associated with minimal or mild endometriosis: a controlled randomized study. Fértil Steril 1992;58:28–31.PubMedGoogle Scholar
  30. 30.
    Medical Research International Society for Assisted Reproductive Technology, American Fertility Society. In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1989 results from the IVF-ET registry. Fértil Steril 1991;55:14–23.Google Scholar
  31. 31.
    Olive DL, Schwartz Barne L. Endometriosis. N Engl J Med 1993;328:1759–69.PubMedCrossRefGoogle Scholar
  32. 32.
    Overcoming endometriosis: new help from the Endometriosis Association. Milwaukee: Endometriosis Association.Google Scholar
  33. 33.
    American College of Obstetrics and Gynecologists. Important facts about endometriosis. Washington, DC: ACOG.Google Scholar
  34. 34.
    Horn MC, Mosher WD. Use of services for family planning and infertility. United States, 1982, Advance data from vital and health statistics. No. 103. Hyattsville, MD: U.S. Public Health Service, Department of Health and Human Services, 1984.Google Scholar
  35. 35.
    Mosher WD. Infertility trends among U.S. couples: 1965–1976. Fam Plann Perspect 1982;14:22–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Speroff L, Glass RH, Kase NG, editors. Investigation of the infertile couple. 4th ed. Baltimore: Williams & Wilkins, 1989: 513–46.Google Scholar
  37. 37.
    Zarutskie PW. Evaluation of the infertile couple. In: Stenchever MA, editor. Office gynecology. St. Louis: Mosby Year Book, 1992:441–70.Google Scholar
  38. 38.
    American College of Obstetricians and Gynecologists. Infertility. Washington, DC: ACOG, 1989. Technical Bulletin No. 125.Google Scholar
  39. 39.
    Davajan V. Workup of the infertile couple. In: Mishell DR, Brenner PF, editors. Management of common problems in obstetrics and gynecology. Oradell, NJ: Medical Economics Books, 1984:387–93.Google Scholar
  40. 40.
    Whittermore AS, Hams R, Intyre J, Halpern J. The Collaborative Ovarian Cancer Group: characteristics relating to ovarian cancer risk: collaberative analysis of twelve US case-control studies I-IV. Am J Epidemiol 1992;136:1175–220.Google Scholar
  41. 41.
    Todd J, Fishaut M. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978;2:1116–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Tofte RW, Williams DN. Toxic shock syndrome: evidence of a broad clinical spectrum. JAMA 1981;246:2163–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Bryner CL Jr. Recurrent toxic shock syndrome. Am Fam Physician 1989;39:157–64.PubMedGoogle Scholar
  44. 44.
    Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 1980;303:1429–35.PubMedCrossRefGoogle Scholar
  45. 45.
    Centers for Disease Control. Summary of notifiable disease, United States. MMWR 1988;37:40.Google Scholar
  46. 46.
    Litt IF. Toxic shock syndrome—an adolescent disease. J Ad-olesc Health Care 1983;4:270–4.CrossRefGoogle Scholar
  47. 47.
    Reingold AL, Hargrett NT, Dan BB, Shands KN, Strickland BY, Broome CV. Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med 1982;96:871–4.PubMedCrossRefGoogle Scholar
  48. 48.
    Gallo UE, Fontanarosa PB. Toxic streptococcal syndrome. Ann Intern Med 1990;19:1332–4.Google Scholar
  49. 49.
    Wolf J, Rabinowitz L. Streptococcal toxic shock like syndrome. Arch Dermatol 1995;131:73–7.PubMedCrossRefGoogle Scholar
  50. 50.
    Resnick SD. Toxic shock syndrome: recent developments in pathogenesis. J Pediatr 1990;116:321–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Parsonnet J. Mediators in the pathogenesis of toxic shock syndrome: overview. Rev Infect Dis 1989;2 Suppl 1:s263–9.CrossRefGoogle Scholar
  52. 52.
    Tofte R, Williams DN. Toxic shock syndrome: clinical and laboratory features in 15 patients. Ann Intern Med 1981; 94:149–56.PubMedCrossRefGoogle Scholar
  53. 53.
    Davis JP, Osterholm MT, Helms CM, et al. Tri-state toxic-shock syndrome study: clinical and laboratory findings. J Infect Dis 1982;145:441–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Todd JK. Therapy of toxic shock syndrome. Drugs 1990;39: 856–61.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Gary R. Newkirk
  • Patricia Ann McGuire

There are no affiliations available

Personalised recommendations